Market Overview:
The global cardiotoxicity screening market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cardiotoxicity, rising demand for early detection and diagnosis of cardiotoxicity, and growing number of clinical trials. The global cardiotoxicity screening market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into reagents and services. The reagents segment is further sub-segmented into kits and assays. The services segment is further sub-segmented into contract research organization (CRO), pharmaceutical company, academic and research institutes (ARI), and others (including biotechnology companies). On the basis of application, the market is divided into drug discovery & development phase I-IV studies; preclinical studies; postmarketing surveillance; pharmacovigilance; risk assessment & management consulting services; others (including toxicology testing). Geographically, it has been analyzed across North America (U.S., Canada), Latin America (Mexico Brazil), Europe(Germany France Italy Spain U K.), Asia Pacific(Japan China India Australia South Korea)and Middle East Africa(Saudi Arabia UAE Qatar South Africa).
Product Definition:
Cardiotoxicity is a potential toxicity of certain drugs, particularly chemotherapeutic agents, that affects the heart. Cardiotoxicity screening is a test used to detect this type of toxicity. The importance of cardiotoxicity screening is that it can help identify patients who are at risk for developing heart problems as a result of their cancer treatment. This information can then be used to help design individualized treatment plans that minimize the risk of cardiac complications.
Reagent:
Reagents are chemicals that help in the detection of specific substances. They can be used for various applications such as medical diagnosis, agriculture, and food testing. The global reagent market is expected to witness significant growth over the forecast period owing to its increasing use in cardiotoxicity screening market. Reagents are extensively used during drug discovery processes which include cardiovascular toxicity screening by using cardiac biomarkers or cardiac markers.
Service:
Service and it's usage in Cardiotoxicity Screening market: Introduction Service is a software application that helps healthcare professionals to manage their workflow effectively. It also helps them to improve the quality of patient care by providing clinical information management tools. The primary function of service is to automate tasks which are done manually, thus saving time and increasing efficiency.
The global cardiotoxicity screening market size was valued at USD 0.00 in 2016.
Application Insights:
The contract research organization segment dominated the global cardiotoxicity screening market in 2017. Factors such as an increase in the number of government and private-sector initiatives to reduce healthcare expenditure coupled with a rise in demand for cost-effective solutions are anticipated to drive this segment over the forecast period.
Cardiac toxicity screening is carried out during preclinical testing phases for new drug development programs or when a new drug candidate is being tested in humans. In some cases, it may be required when an existing drug candidate has failed clinical trials or there are concerns regarding long-term risks associated with its use. The presence of multiple companies involved in various stages of clinical development and ongoing research activities further contributes towards segment growth.
The academic and research institutes application segment accounted for revenue share of 20% globally on account of increasing collaborations between pharmaceutical companies and leading medical institutions across the globe, especially within Europe.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of companies involved in drug development and approval, which has resulted in higher incidence of cardiotoxicity during drug development. In addition, growing focus on novel therapies for cardiac diseases is expected to drive growth over the forecast period.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing outsourcing activities by North American and European companies coupled with rising R&D expenditure by these entities in this region. The availability of skilled professionals at a low cost along with easy access to patient pool is also contributing toward regional growth. Moreover, government initiatives such as “Make in India†campaign undertaken by Indian government are likely boost manufacturing sector within country leading to increased demand for screening services from contract research organizations (CROs).
Moreover, economic strides made within countries such as China.
Growth Factors:
- Increasing incidence of cardiotoxicity: Cardiotoxicity is a growing global health concern, with the number of people affected by it on the rise. This is primarily due to the increasing incidence of cardiovascular diseases and cancer. As a result, there is an increased demand for cardiotoxicity screening services.
- Advances in technology: The development of new and innovative technologies has led to the emergence of novel screening methods for detecting cardiotoxicity early on. This has helped to boost the growth of the market considerably.
- Growing awareness about cardiotoxicity: There is a growing awareness among people about the dangers posed by cardiotoxic substances and drugs. This has led to an increase in demand for preventive measures such as screenings for early detection and treatment options..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiotoxicity Screening Market Research Report
By Type
Reagent, Service
By Application
Contract Research Organization, Pharmaceutical Company, Academic and Research Institutes, Others
By Companies
Admescope Ltd, Stemina Biomarker Discovery, Cyprotex, Eurofins Discovery, Axol Bioscience Ltd, Molecular Devices, AMRI Global, GVK Biosciences, WuXi AppTec, Anbiqi Biotechnology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Cardiotoxicity Screening Market Report Segments:
The global Cardiotoxicity Screening market is segmented on the basis of:
Types
Reagent, Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Contract Research Organization, Pharmaceutical Company, Academic and Research Institutes, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Admescope Ltd
- Stemina Biomarker Discovery
- Cyprotex
- Eurofins Discovery
- Axol Bioscience Ltd
- Molecular Devices
- AMRI Global
- GVK Biosciences
- WuXi AppTec
- Anbiqi Biotechnology
Highlights of The Cardiotoxicity Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagent
- Service
- By Application:
- Contract Research Organization
- Pharmaceutical Company
- Academic and Research Institutes
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiotoxicity Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiotoxicity screening is a process used to identify potential health risks associated with exposure to cardiotoxic substances. This includes identifying any potential damage done to the heart muscle and other organs as a result of exposure.
Some of the key players operating in the cardiotoxicity screening market are Admescope Ltd, Stemina Biomarker Discovery, Cyprotex, Eurofins Discovery, Axol Bioscience Ltd, Molecular Devices, AMRI Global, GVK Biosciences, WuXi AppTec, Anbiqi Biotechnology.
The cardiotoxicity screening market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiotoxicity Screening Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiotoxicity Screening Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiotoxicity Screening Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiotoxicity Screening Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiotoxicity Screening Market Size & Forecast, 2018-2028
4.5.1 Cardiotoxicity Screening Market Size and Y-o-Y Growth
4.5.2 Cardiotoxicity Screening Market Absolute $ Opportunity
Chapter 5 Global Cardiotoxicity Screening Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cardiotoxicity Screening Market Size Forecast by Type
5.2.1 Reagent
5.2.2 Service
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cardiotoxicity Screening Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cardiotoxicity Screening Market Size Forecast by Applications
6.2.1 Contract Research Organization
6.2.2 Pharmaceutical Company
6.2.3 Academic and Research Institutes
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiotoxicity Screening Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiotoxicity Screening Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cardiotoxicity Screening Analysis and Forecast
9.1 Introduction
9.2 North America Cardiotoxicity Screening Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cardiotoxicity Screening Market Size Forecast by Type
9.6.1 Reagent
9.6.2 Service
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cardiotoxicity Screening Market Size Forecast by Applications
9.10.1 Contract Research Organization
9.10.2 Pharmaceutical Company
9.10.3 Academic and Research Institutes
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cardiotoxicity Screening Analysis and Forecast
10.1 Introduction
10.2 Europe Cardiotoxicity Screening Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cardiotoxicity Screening Market Size Forecast by Type
10.6.1 Reagent
10.6.2 Service
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cardiotoxicity Screening Market Size Forecast by Applications
10.10.1 Contract Research Organization
10.10.2 Pharmaceutical Company
10.10.3 Academic and Research Institutes
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cardiotoxicity Screening Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cardiotoxicity Screening Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cardiotoxicity Screening Market Size Forecast by Type
11.6.1 Reagent
11.6.2 Service
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cardiotoxicity Screening Market Size Forecast by Applications
11.10.1 Contract Research Organization
11.10.2 Pharmaceutical Company
11.10.3 Academic and Research Institutes
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cardiotoxicity Screening Analysis and Forecast
12.1 Introduction
12.2 Latin America Cardiotoxicity Screening Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cardiotoxicity Screening Market Size Forecast by Type
12.6.1 Reagent
12.6.2 Service
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cardiotoxicity Screening Market Size Forecast by Applications
12.10.1 Contract Research Organization
12.10.2 Pharmaceutical Company
12.10.3 Academic and Research Institutes
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cardiotoxicity Screening Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cardiotoxicity Screening Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cardiotoxicity Screening Market Size Forecast by Type
13.6.1 Reagent
13.6.2 Service
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cardiotoxicity Screening Market Size Forecast by Applications
13.10.1 Contract Research Organization
13.10.2 Pharmaceutical Company
13.10.3 Academic and Research Institutes
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiotoxicity Screening Market: Competitive Dashboard
14.2 Global Cardiotoxicity Screening Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Admescope Ltd
14.3.2 Stemina Biomarker Discovery
14.3.3 Cyprotex
14.3.4 Eurofins Discovery
14.3.5 Axol Bioscience Ltd
14.3.6 Molecular Devices
14.3.7 AMRI Global
14.3.8 GVK Biosciences
14.3.9 WuXi AppTec
14.3.10 Anbiqi Biotechnology
